Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Melbourne Brain Centre, Heidelberg

Columbia University - Department of Neurology, New York

Columbia University Medical Center, New York

Neurology & Epilepsy Research Center, Orlando

Miami Children's Research Institute, Miami

Service de Neurologie Pédiatrique et des Maladies Métaboliques - INSERM U1141 Hôpital Robert Debré - APHP, Paris

Cook Children's Hospital, Fort Worth

University of Texas Neurometabolic Clinic, Houston

Children's Hospital Colorado - University of Colorado, Denver, School of Medicine, Aurora

Seattle Children's Hospital, Seattle

Sheba University Medical Center, Tel Aviv

"Unita' Operativa Neurologia Pediatrica e Malattie Muscolari Istituto Giannina Gaslini", Genova

Hospital Sant Joan de Deu, Barcelona

Newcastle University, Newcastle upon Tyne